DNA-damaging therapies represent a keystone in cancer treatment. Unfortunately, many tumors often relapse because of a group of cancer cells, which are resistant to conventional therapies. High-mobility group A (HMGA) proteins has a key role in cell transformation, and their overexpression is a common feature of human malignant neoplasias, representing a poor prognostic index often correlated to anti-cancer drug resistance. Our previous results demonstrated that HMGA1 is a substrate of ataxiatelangiectasia mutated (ATM), the main cellular sensor of genotoxic stress. Here we also report thatHMGA2, the other member of the HMGA family, is a novel substrate of ATM. Interestingly, we found that HMGA proteins positively regulate ATM gene expression. Moreover, induction of ATM kinase activity by DNA-damaging agents enhances HMGA-dependent transcriptional activation of ATM promoter, suggesting that ATM expression is modulated by a DNA-damage-and HMGA-dependent positive feedback loop. Finally, inhibition of HMGA expression in mouse embryonic fibroblasts and in cancer cells strongly reduces ATM protein levels, impairing the cellular DNA-damage response and enhancing the sensitivity to DNA-damaging agents. These findings indicate this novel HMGA-ATM pathway as a new potential target to improve the effectiveness of conventional anti-neoplastic treatments on the genotoxic-drug resistant cancer cells.
Introduction
The high-mobility group A (HMGA) protein family includes four members: HMGA1a, HMGA1b and HMGA1c (encoded by the HMGA1 gene through alternative splicings) and HMGA2 (encoded by the HMGA2 gene) (Johnson et al., 1989; Nagpal et al., 1999) . HMGA proteins bind the minor groove of AT-rich DNA regions, through their amino-terminal DNA-binding domain, which consists of three short basic repeats, the so-called AT-hooks (Reeves and Nissen, 1990) .
HMGAs are involved in several cellular processes such as gene and micro-RNA expression, chromatin and nucleosome remodeling, DNA replication, apoptosis and DNA repair (Wood et al., 2000; Reeves and Adair, 2005; Fusco and Fedele, 2007; Fedele and Fusco, 2010) . HMGAs also has a causal role in cellular transformation (Wood et al., 2000) , mainly through the regulation of expression of genes and micro-RNA involved in the control of cellular proliferation, invasion and apoptosis (Reeves and Adair, 2005; Fusco and Fedele, 2007; Fedele and Fusco, 2010) .
Expression of both HMGA genes is restricted to the embryogenesis, resulting low or absent in normal adult tissues (Zhou et al., 1995; Chiappetta et al., 1996) , while their overexpression is commonly found in almost all human malignant neoplasias, representing a poor prognostic marker correlated with the presence of metastasis, reduced survival and resistance to anticancer therapies (Fusco and Fedele, 2007; Fedele and Fusco, 2010) .
We have previously shown that HMGA1 is a novel target of the ataxia-telangiectasia mutated (ATM) protein (Pentimalli et al., 2008) , the main cellular sensor of DNA damage. Following the exposure to genotoxic agents, the serine/threonine kinase ATM directly and indirectly phosphorylates several substrates in order to orchestrate the cellular DNA-damage response (DDR), activating a signaling cascade which induces DNA repair, cell-cycle checkpoint activation and, eventually, apoptosis or senescence (Lavin, 2008) . Interestingly, ATM-deficient cells display an increased sensitivity to genotoxic agents (Meyn et al., 1994; Savitsky et al., 1995; Ku¨hne et al., 2004) , and chemical inhibition of ATM induces cellular chemo-and radio-resistance (Sarkaria et al., 1998 (Sarkaria et al., , 1999 Sarkaria and Eshleman 2001) .
In the present study, we demonstrate that HMGA2 also binds and is phosphorylated by ATM. Moreover, based on the widely described role of HMGAs in the regulation of gene expression (Reeves and Adair, 2005; Fusco and Fedele, 2007; Fedele and Fusco, 2010) , we investigated their ability to bind and regulate the ATM gene promoter. Our results indicate that HMGAs positively regulate ATM expression and that ATM kinase activity on HMGA proteins can enhance their transcriptional activity on this promoter, activating a HMGA-dependent positive feedback loop in response to DNA damage. Accordingly, Hmga1/2 double knockout mouse embryonic fibroblasts (MEFs) display very low levels of ATM and an impaired DDR.
Finally, we report that block of HMGA expression in anaplastic thyroid cancer cells reduces cellular levels of ATM, impairs the DDR and enhances the cellular sensitivity to genotoxic agents such as ionizing radiations.
Results

HMGA2 interacts with and is phosphorylated by ATM
The carboxy-terminal domain of HMGA2 harbors a SQ motif (O'Neill et al., 2000) (serine 102/glutamine 103), which corresponds to the serine 88/glutamine 89 of HMGA1, phosphorylated by ATM (Pentimalli et al., 2008) . Therefore, we investigated whether HMGA2 is also a novel target of ATM kinase activity (Figure1 and Supplementary Figure S1 ). For this purpose, we evaluated the ability of HMGA2 to interact with ATM transfecting HEK-293 cells with hemagglutinin (HA)-tagged-HMGA2 and FLAG-tagged-ATM expression vectors ( Figure 1a) . Cell extracts were immunoprecipitated with anti-FLAG antibody and immunoblotted with anti-HA antibody. Co-transfection of both HMGA2 and ATM resulted in co-immunoprecipitation of the two proteins. Conversely, HMGA2 was not immunoprecipitated by the anti-FLAG antibody when HA-HMGA2 expression vector was transfected alone. Co-immunoprecipitation experiments performed also in the presence of ethidium bromide demonstrated that the co-immunoprecipitation between HMGA2 and ATM did not depend on the contaminating DNA.
Moreover, we immunoprecipitated cell extracts from HEK-293 transfected with HA-HMGA2 expression vector alone using the anti-HA antibody, and immunoprecipitates were analyzed by western blot using anti-ATM antibody. As shown in Supplementary Figure S1 , HA-HMGA2 was also able to interact with the endogenous ATM protein. Then, we verified that HMGA2, as HMGA1, is a novel substrate of ATM kinase activity in response to DNA damage. HEK-293 were transfected with HA-HMGA2 expression vector, and endogenous ATM kinase activity was induced by treating cells with 10 Gy of infrared (IR). Cells were collected 30 min after the treatment and total cell lysates were immunoprecipitated using antibodies raised against phospho-serine and phospho-threonine residues phosphorylated by ATM (Anti-P-Sub-ATM).
Immunoprecipitated ATM substrates were analyzed by immunoblot using anti-HA antibody, which revealed a band corresponding to the HA-HMGA2 protein (Figure 1b) . Conversely, HA-HMGA2 was immunoprecipitated by the Anti-P-Sub-ATM also in cells not treated with IR. However, IR treatment significantly increased the amount of immunoprecipitated HA-HMGA2, and selective inhibition of ATM kinase activity, treating cells with 10 mM KU-55933, a specific inhibitor of ATM (Hickson et al., 2004) , for 1 h before the IR exposure, abrogated the binding of Anti-P-Sub-ATM antibody to HA-HMGA2. These data indicate that HMGA2 is phosphorylated also in undamaged cells, but ATM activation have a key role in this phosphorylation following DNA-damaging agents exposure.
HMGA1 and HMGA2 positively regulate ATM expression It is well known that HMGA proteins positively or negatively regulate the transcriptional activity of several genes (Fedele et al., 2001a, b; Fusco and Fedele, 2007; Fedele and Fusco, 2010) . Therefore, we evaluated the possible role of HMGA proteins in the regulation of ATM expression (Figure 2 ). To this aim, we analyzed the expression levels of ATM mRNA and protein in MEFs lacking one or both Hmga genes (De Martino et al., manuscript in preparation) . Expression levels of ATM are strongly influenced by the presence of HMGA proteins. In fact, ATM mRNA and total protein levels were strongly reduced in MEFs carrying one disrupted (a) HEK-293 cells were transfected as indicated, and total cell extracts were immunoprecipitated using anti-FLAG antibody. Immunoprecipitated proteins were analyzed by western blot using anti-HA or anti-FLAG antibodies. Where indicated, ethidium bromide (EtBr) was added during immunoprecipitations. Cells transfected with the HA-HMGA2 vector alone were used as negative control. (b) HEK-293 cells transfected with the HA-HMGA2 vector were treated or not with a 10 Gy dose of IR and harvested after 30 min. Cell extracts were immunoprecipitated using the anti-P-Sub-ATM antibody. Inputs (upper panel) and immunoprecipitates (lower panel) were analyzed by western blot using anti-HA antibody. As a control of the specificity of phosphorylation, cells were also pre-treated with 10 mM KU-55933 for 1 h before the treatment with IR. (Figure 2b ). Accordingly, reduced levels of active ATM, assessed using an antibody directed against its phophorylated serine 1981 (ATMser1981), were also observed in Hmga1/2 double knock-out (DKO) MEFs compared with wild-type controls. The faint signal that is observed in wild-type and Hmga1 or Hmga2 single knock-out MEFs is likely due to the minimal ATM activation often observed in primary culture cells, particularly when grown in a typical cell culture incubator with 20% pO 2 (Parrinello et al., 2003) . Moreover, we treated wild-type, Hmga1 KO, Hmga2 KO and Hmga1/2 DKO MEFs with 5 Gy of IR to evaluate the activation of ATM using the anti-ATMser1981 antibody, and we found that ATM activation following the IR treatment was significantly decreased in Hmga1-KO and Hmga2-KO MEFs, and almost absent in Hmga1/2-DKO MEFs as shown in Supplementary Figure S2 . These observations suggested that both HMGA proteins have a positive role in the control of ATM expression, leading us to further investigate a possible impairment of ATM-downstream pathways in Hmga1/2 DKO MEFs.
To investigate whether HMGA proteins bind ATM promoter, we performed chromatin-immunoprecipitation experiments using both human HEK-293T ( Figure 2c ) and murine NIH-3T3 (Supplementary Figure S3 ) cells transiently transfected with either HA-HMGA1 or HA-HMGA2 expression vectors. Chromatin was immunoprecipitated using anti-HA or normal rabbit IgG antibodies. As shown in Figure 2c and Supplementary Figure S3 , the ATM promoter was amplified only from the DNA recovered with anti-HA antibody in both 293T and NIH-3T3 cells transfected with HA-HMGA1 or HA-HMGA2, but not in cells transfected with the empty vector pCEFL-HA, used as a negative control. No amplification was obtained in the samples immunoprecipitated using normal rabbit IgG.
To better characterize the region of ATM promoter bound by HMGA proteins, we used different sets of PCR primers to amplify the DNA immunoprecipitated in the experiment described in Figure 2c . As shown in Supplementary Figure S4 , we demonstrated that the main binding region by HMGA proteins on ATM promoter is located between À400 and À600 bp from the transcription start site of ATM gene. However, we found that HMGA1 was also able to bind the region located between À50 and À400 bp from the transcription start site, while HMGA2 binding was selective for the region À400 to À600 bp from the transcription start site. The specificity of the HMGA binding to ATM promoter was demonstrated as no amplification was observed using primers able to amplify the ATM promoter region between À800 and À1000 bp from the transcription start site.
To confirm the positive effect of HMGA proteins on the ATM promoter, we performed luciferase assays transfecting a construct expressing the luciferase reporter gene under the transcriptional control of the human ATM promoter (pLuc-ATM, region À512 to þ 9) (Berkovich and Ginsberg, 2003) along with HA- Figure  S5D ). Both HA-HMGA1 and HA-HMGA2 upregulate ATM promoter in PC Cl 3 cells, which express very low levels of endogenous HMGAs (Supplementary Figure  S5E) . Moreover, we also transfected PC Cl 3 cells with C-terminal deletion mutants of HA-HMGA1 (HA-HMGA1 (1-43)) and HA-HMGA2 (HA-HMGA2 (1-73)), as shown in Supplementary Figure S6 , these mutants were unable to activate ATM promoter.
To confirm the results obtained with the previously shown cell lines, we transfected the pLuc-ATM reporter plasmid in wild-type, Hmga1 KO, Hmga2 KO and Hmga1/2 DKO MEFs. Figure 2d shows that transcriptional activity of ATM promoter is strongly dependent on the presence of HMGA proteins. In fact, absence of HMGA1, HMGA2 or both HMGA proteins significantly reduces ATM promoter activity, accordingly with the results obtained from semi-quantitative RT-PCR and western blot experiments (Figures 2a and b) .
Finally, we transfected the HA-HMGA1, HA-HMGA2 and their transcriptionally inactive deletion mutants HA-HMGA1 (1-43) and HA-HMGA2 (1-73) expression vectors in Hmga1/2 DKO MEFs, and evaluated ATM mRNA levels by real time-PCR. As shown in Supplementary Figure S7 , re-expression of the full-length HMGA proteins, but not the transcriptionally inactive mutants, rescued ATM expression.
Phosphorylation of HMGA proteins by ATM enhances their transcriptional activity on ATM promoter ATM activation by DNA-damaging agents determines the phosphorylation of many substrates, in order to trigger an effective cellular response to the DNA damage (Lavin and Kozlov, 2007) . Therefore, we hypothesized that ATM-dependent phosphorylation of HMGA1 and HMGA2 could have a role in the modulation of their function following the exposure to DNA-damaging agents. Then, we performed luciferase assays in PC Cl 3 cells transfected with HA-HMGA1 ( Figure 3a ) or HA-HMGA2 ( Figure 3b ) expression vectors along with the reporter construct pLuc-ATM, and assessed ATM promoter activity following the exposure to IR. Twenty-four hours after the transfection, cells were treated or not with 3 Gy of IR, in order to activate ATM kinase activity. As a specificity control, cells were also pre-incubated with KU-55933 for 1 h. As shown in Figures 3a and b, both IR and KU-55933 do not affect the transcriptional activity of ATM promoter in the absence of HMGA proteins, while IR enhanced HMGA-dependent upregulation of this promoter in cells transfected with either HA-HMGA1 or HA-HMGA2. Conversely, the KU-55933 prevents the IR-dependent increase of HMGA activity on ATM promoter, indicating that this effect depends on ATM.
MEFs null for both Hmga genes display low levels of p21 mRNA and reduced phosphorylation of p53. Previous studies on AtmÀ/À MEFs have indicated a significant involvement of p53 and p21 in cellular defects dependent on the absence of ATM (Xu et al., 1996 (Xu et al., , 1998 . In fact, following DNA damage, ATM phosphorylates p53 and enhances its transcriptional activity on several target promoters, such as p21 (Lavin and Kozlov 2007) . Therefore, we first analyzed the levels of p53 phosphorylation on the residue (serine 15) that is phosphorylated by ATM (Canman et al., 1998) . Accordingly to the reduced expression of ATM in Hmga1/2 DKO MEFs, we found that the absence of HMGA proteins reduces the levels of p53-pSer15 (Figure 4a ). Conversely, p53 phosphorylation levels in Hmga1 KO MEFs are comparable to those observed in wild-type MEFs, while we observed a significant reduction of p53ser15 in Hmga2 KO MEFs in comparison with wild-type MEFs. Moreover, the absence of both Hmga genes almost abolishes the levels of p21 mRNA (Figure 4a ). However, Hmga1 KO MEFs show a slight reduction of p21 mRNA, while Hmga2 KO MEFs express p21 mRNA levels comparable to HMGAs regulate cellular DNA-damage response D Palmieri et al Hmga1/2 DKO MEFs. These data clearly indicate that disruption of both Hmga genes drastically affects the ATM-dependent p53/p21 pathway, reducing p53 phosphorylation and p21 gene expression.
MEFs lacking Hmga genes display an altered ability to repair DNA damage The data discussed above led us to investigate the biological effect of the HMGA proteins in DDR. To this aim, we analyzed the DNA-repair ability following IR exposure of MEFs lacking one or both Hmga genes. Wild-type, Hmga1 KO, Hmga2 KO and Hmga1/2 DKO MEFs were either treated or not with 4 Gy of IR to induce DNA-double strand breaks (DSBs) and activate cellular DDR. Cells were harvested before or immediately after the treatment, or were allowed to repair DNA damage for 3 h. Then, we analyzed the amount of damaged DNA in each cell type by comet assay, evaluating the comet tail moment as a measure of the DNA damage. MEFs of all four genotypes display similar levels of DNA damage before and immediately after the treatment with IR compared with wild-type MEFs (Figure 4b and Supplementary Figure S8) . However, after 3 h, wild-type and single knock-out MEFs almost completely recover the damage, while Hmga1/2 DKO MEFs still show significant levels of damaged DNA (Figure 4b and Supplementary Figure  S8 ). These observations suggest that absence of both HMGA proteins determines a significant impairment of the DNA-damage repair machinery, and reduced ATM levels might, at least in part, account for this phenotype. However, the presence of at least one of the two Hmga genes is sufficient to sustain the cellular DNA-damage repair.
Absence of HMGA proteins prevents stress-induced senescence As previously described, ATM also have a key role in cellular senescence, following genotoxic stress (Crescenzi et Hmga2 KO MEFs, while Hmga1 KO and Hmga1/2 DKO MEFs were almost refractory to the stressinduced senescence. This result suggests that absence of both HMGA1 and HMGA2 prevents stress-induced senescence, likely because of the low cellular levels of ATM. Moreover, HMGA1 seems to be more involved than HMGA2 in this process, because only Hmga1 KO, but not Hmga2 KO cells, are resistant to stress-induced senescence.
Downregulation of HMGA1 protein enhances cancer cell sensitivity to DNA damage An accumulating body of evidence indicates that inhibition of ATM kinase activity enhances cellular sensitivity to DNA-damaging agents (Jackson et al., 2009 ). These findings suggest that inhibition of HMGA proteins, affecting ATM expression, may result in the reduction of the ATM-mediated DDR and improvement of cell sensitivity to DNA-damaging agents.
To validate this hypothesis, we analyzed the DDR of FRO (human thyroid anaplastic cancer cells, which express high levels of HMGA1 but not HMGA2) and FRO-asHMGA1 cells, that stably express an anti-HMGA1 antisense construct (Berlingieri et al., 2002) . As shown in Figure 5a , FRO-asHMGA1 display reduced levels of HMGA1 and of ATM protein compared with FRO parental cells. Accordingly, following the exposure of parental FRO and FRO-asHMGA1 to 5 Gy of IR, we found a reduced activation of ATM and its downstream pathways. In fact, IR treatment significantly increased ATMpSer1981, CHK2pThr68 and total p21 levels only in parental FRO but not in FRO-asHMGA1 cells, as shown by western blot analysis (Supplementary Figure S9) .
Subsequently, we confirmed HMGA-dependent upregulation of ATM also in this cellular system. Indeed, we treated parental FRO and FRO-asHMGA1 cells with 5 Gy of IR and cells were then harvested at 72 h from the treatment to evaluate ATM mRNA levels by real time-PCR. As shown in Supplementary Figure S10 , IR exposure increased ATM mRNA levels only in FRO but not in FRO-asHMGA1.
Then, we performed a clonogenic assay on FRO and FRO-asHMGA1 following the exposure to 2.5 or 5 Gy To analyze the efficacy of the DNA-damage repair machinery in the absence of HMGA1, we performed a comet assay using parental FRO and FRO-asHMGA1 cells, treated or not with 5 Gy of IR. Cells were analyzed immediately or 3 h after the exposure to IR, and the tail moment of comets was analyzed. As shown in Figures  5c and d , we found significant differences in damaged DNA between wild-type FRO and FRO-asHMGA1 cells 3 h after the treatment with IR, while the amount of damaged DNA is almost comparable in untreated cells or immediately after the exposure to IR. These results indicate that, following the exposure to DNA-damaging agents, FRO-asHMGA1 activate a less effective DNArepair machinery compared with wild-type FRO cells.
To further confirm that the reduced survival and DNA-repair ability of FRO-asHMGA1 cells following IR exposure was dependent on the lack of the transcriptional activation of ATM by HMGA1, we stably transfected FRO-asHMGA1 cells with the pFLAG-ATM expression vector (FRO-asHMGA1-ATM) or the pFLAG empty vector (FRO-asHMGA1-FLAG) (Supplementary Figure 11A) . Then, we performed a clonogenic assay following the exposure to 5 Gy of IR on FRO-asHMGA1-ATM, FRO-asHM-GA1-FLAG and parental FRO cells. As shown in Supplementary Figure S11B , the number of colonies formed by FRO and FRO-asHMGA1-ATM cells following the IR treatment was significantly higher compared with FRO-asHMGA1-FLAG cells. Moreover, we analyzed the DNA repair ability of FROasHMGA1-ATM cells by comet assay as previously described, following the exposure to 5 Gy of IR.
Supplementary Figure S11C and S11D show that, 3 h after the IR treatment, the tail moment of FROasHMGA1-ATM cells was similar to parental FRO cells and significantly lower compared with FRO-asHM-GA1-FLAG cells.
Next, we analyzed cell-cycle progression following IR exposure, in order to evaluate the ATM-dependent activation of cell-cycle checkpoints in response to DNA damage. Asynchronously growing FRO and FROasHMGA1 cells were harvested at different time-points following the exposure to 5 Gy of IR, fixed and stained with propidium iodide, and analyzed by flow cytometry. As shown in Figure 6 , 16 and 24 h after IR treatment, parental FRO cells arrests cell-cycle progression in G1 and S phase more efficiently compared with FROasHMGA1. Accordingly, activation of the G1/S checkpoint following the exposure to UV-light was less efficient in FRO-asHMGA1 than in wild-type FRO cells (data not shown). These data suggest that abrogation of HMGA1 expression in cancer cells reduces the DDR, affecting the ATM-dependent activation of cellcycle checkpoints. To focus our attention on G1/S and intra-S checkpoints, FRO and FRO-asHMGA1 were treated with 0.2 mg/ml of nocodazole following the exposure to 5 Gy of IR, in order to prevent cells from exiting G2/M phase and re-entering in G1. Wild-type FRO were also treated with 10 mM of KU-55933 to assess the effects of ATM inhibition. Cells were harvested 8 h after the nocodazole treatment, and analyzed by flow cytometry. As shown in Supplementary Figure S12 , cell-cycle progression from G1 to G2 is significantly slower in FRO cells than in FRO cells treated with KU-55933 and FRO-asHMGA1 cells, following the treatment with IR and nocodazole. To better quantify the G1 checkpoint activation in FRO and FRO-asHMGA1 cells, we performed BrdU incorporation assays in these cells following IR exposure. Cells were synchronized in G1 phase by thymidine double block, then treated with 5 Gy of IR and released in complete medium containing 1 mM BrdU. Cells were harvested at different time-points and stained using an anti-BrdU antibody. BrdU incorporation was then evaluated by flow cytometry analysis. As shown in Supplementary Figure S13 , BrdU incorporation was significantly higher in FRO-asHMGA1 compared with parental FRO cells after the IR treatment. These results further support the idea that block of HMGA1 expression in cancer cells prevents ATM induced G1/S checkpoint. Then, we hypothesized that HMGA1, sustaining the expression levels of ATM, promotes the activation of G1/S checkpoint in response to DNA damage to slow down the cell-cycle progression in order to repair DNA and prevent DNA-damaging agents-induced apoptosis. To verify this hypothesis, we analyzed apoptotic markers such as annexin-V staining and caspase 3/7 activation in FRO and FRO-asHMGA1 cells, following IR treatment (Figure 7) . Parental FRO and FRO-asHMGA1 cells were treated with 5 Gy of IR, harvested after 24 h, stained with anti-annexin-V fluorescent antibody and analyzed by flow cytometry. Annexin-V staining confirmed that FRO-asHMGA1 cells display a higher percentage of apoptotic cells already in untreated cells, compared with parental FRO (Figure 7a ). However, following IR exposure, both FRO and FRO-asHMGA1 cells undergo apoptosis, but a significant higher percentage of annexin-V positive cells was found in FRO-asHMGA1 than in parental cells (Figure 7a ). Consistently with this result, FRO-asHM-GA1 cells display an increased basal caspase 3 and 7 activity compared with parental cells following the exposure to 2.5 and 5 Gy of IR (Figure 7b ). However, 8 h after IR treatment, we observed a significant increase in caspase 3 and 7 activation, which increased until 24 h after the exposure only in FRO-asHMGA1 cells. Conversely, parental FRO cells show a slower and less intense activation of apoptotic pathways (Figure 7b) . Therefore, these data clearly indicate that inhibition of HMGA expression in cancer cells effectively enhances DNA-damage-dependent apoptosis.
Discussion
HMGAs has a causal role in the process of carcinogenesis, and their overexpression is often correlated with resistance to conventional anti-cancer therapies and a poor prognosis (Fusco and Fedele, 2007) . Previously, we reported that HMGA1 is a novel target of ATM following DNA damage (Pentimalli et al., 2008) . Here, we demonstrate that also HMGA2, the other member of HMGA family, interacts and is specifically phosphorylated by ATM following the exposure to IR, and that this phosphorylation can be prevented by chemical inhibition by ATM kinase activity.
Then, we investigated the potential role of HMGA proteins in the activation of ATM expression. Our results show that HMGA proteins bind and positively regulate the ATM promoter. Accordingly, MEFs null for Hmga1 or Hmga2 display reduced levels of ATM, compared with wild-type control, while the absence of both Hmga genes completely impairs ATM expression.
As it has been widely demonstrated that HMGA1 and HMGA2 show overlapping functions (Fusco and Fedele, 2007) , our results strongly suggest that HMGA proteins have an additive effect also in the regulation of ATM promoter.
Moreover, our data suggest that ATM activation by IR might trigger a positive feedback loop on its own promoter, which is dependent on the presence of HMGA proteins. In fact, luciferase, real time and western blot experiments performed in different cellular systems showed that, following IR exposure, ATM promoter activity and ATM mRNA and protein levels are enhanced in an ATM-and HMGA-dependent manner. However, the model that we hypothesize will require further studies in order to be clearly confirmed and clarified.
Absence of both Hmga genes results in the abrogation of the p53 phosphorylation on the serine 15 residue and of p21 expression, downstream targets of ATM. Conversely Hmga1 KO MEFs did not show a reduction in the p53/p21 pathway, while Hmga2 KO MEFs displayed reduced levels of p21 mRNA and p53ser15 compared with wild-type MEFs. The absence of Hmga1-dependent inhibition of p53 (Pierantoni et al., 2006; Pierantoni et al., 2007) may account for this difference between Hmga1 and Hmga2 single knock-out MEFs. Our results also indicate a key role for HMGA proteins in the cellular DDR. In fact, Hmga1/2 DKO MEFs repair DNA less efficiently than wild-type MEFs following IR exposure. Moreover, we show that Hmga1/ 2 DKO MEFs fail to undergo stress-induced senescence following IR treatment, further supporting the previously reported role of HMGA proteins in the process of cellular senescence (Narita et al., 2006) . We hypothesize that reduced levels of ATM observed in Hmga1/2 DKO cells may be, at least in part, responsible of this phenotype. However, it is very likely that HMGA1 and HMGA2 might differently affect ATM-downstream pathways and the DDR through the regulation of several other genes or transcription factors such as p16 INK4 , p21 and p53. Finally, inhibition of HMGA1 expression through antisense approach drastically decreases cellular levels of ATM in anaplastic thyroid cancer cells, resulting in increased sensitivity of these cells to DNA-damaging agents. In fact, block of HMGA1 enhances the proapoptotic effects of IR, and cell-cycle analysis following the exposure to DNA-damaging agents showed that absence of HMGA proteins affects the activation of the G1/S checkpoint. These findings further support the idea that abrogation of HMGAs results in the accumulation of DNA damages and in an enhanced sensitivity to DNA-damaging agents.
The data reported here suggest the hypothesis that HMGAs might enhance the cellular response to DNA damage, increasing ATM protein levels, and through their previously described anti-apoptotic activity (Pierantoni et al., 2007) , could shift ATM signaling from cell death to cell survival and resistance to genotoxic drugs. However, further experiments are requested to be clearly confirmed and elucidated.
Our data present important clinical implications. As the depletion of HMGA proteins increases the sensitivity of cancer cells to radio-and chemo-therapeutic drugs, the block of the HMGA expression could represent a new therapeutic tool to reduce the resistance of cancer cells to genotoxic anti-cancer therapies. The differential expression of HMGA in neoplastic and normal cells should also allow for the specificity and low toxicity of such therapy. Moreover, as HMGA proteins are overexpressed in cancers of different origins, HMGA-based therapy should have a wide spectrum of anti-cancer applications.
Materials and methods
Chemicals and treatments
For g-irradiation experiments, cells were irradiated by 6 MV X-ray of a linear accelerator with doses ranging from 0 to 10 Gy. For ATM inhibition experiments, cells were treated with KU-55933 (10 mM) for 1 h before the induction of ATM kinase activity.
Cell cultures, transfections and plasmids HEK-293T, HEK-293, MCF-7, SAOS-2, HeLa and FRO cells were cultured in Dulbecco's modified eagle medium (DMEM) with 10% fetal bovine serum (FBS), L-glutamine and antibiotics (Invitrogen, Carlsbad, CA, USA). PC Cl 3 cells were grown as previously described (Fedele et al., 2001a, b) . MEFs were established from 14.5 dpc embryos following standard procedures, and cultured in DMEM with 10% FBS, L-glutamine, antibiotics and 1% non-essential amino acids (Invitrogen). NIH-3T3 cells were grown in DMEM with 10% FCS and antibiotics. MEFs and FRO cells were transfected using Neon Electroporation System (Invitrogen) according to the manufacturer's instructions. All the other transfections were performed by using Lipofectamine 2000 (Invitrogen), as suggested by the manufacturer. The pCEFL-HA-HMGA1, pCEFL-HA-HMGA2, pCEFL-HA-HMGA1 (1-43) and pCEFL-HA-HMGA2 (1-73) vectors were previously described (Fedele et al., 2006; Pierantoni et al., 2001; Pentimalli et al., 2008) . The anti-HMGA1 antisense construct was described elsewhere (Berlingieri et al., 2002) . The pFLAG-ATM previously described (Bakkenist and Kastan, 2003) was kindly provided by Dr MB Kastan. The pLuc-ATM reporter plasmid was a kind gift of Dr D Ginsberg (Berkovich and Ginsberg, 2003) . Stable clones (FRO-asHMGA1, FRO-as-HMGA1-FLAG and FRO-as-HMGA1-ATM) were generated by co-transfection of the indicated plasmids along with the pBabe-Puro vector, containing the puromycin resistance gene. Following the transfection, stable clones were selected for puromycin resistance in medium containing 1 mg/ml of this antibiotic.
Immunoprecipitation and western blot Protein extraction, western blots and immunoprecipitations were performed as previously described (Pentimalli et al., 2008) . Antibodies used were anti-FLAG M2 (Sigma, St Louis, MO, USA), anti-HA Clone 12CA5 (Roche, Branford, CT, USA), anti-P-ATM-substrate (phospho-Ser/Thr antibody), anti-CHK2pThr68 (Cell Signalling Technology, Danvers, MA, USA), anti-ATM S1981p (Rockland, Philadelphia, PA, USA), anti-p53 DO-1, anti-p-p53 (Ser15), anti-ATM and anti-vinculin (7F9) (Santa Cruz, Santa Cruz, CA, USA). Anti-HMGA1 and anti-HMGA2 polyclonal antibodies were described elsewhere (Pierantoni et al., 2001; Fedele et al., 2006) .
RNA extraction and semi-quantitative (sq)RT-PCR Total RNA was isolated using TRI-reagent solution (Sigma) and treated with DNase (Invitrogen). Reverse transcription was performed according to standard procedures (Applied Biosystems, Foster City, CA, USA). cDNA was amplified by PCR using the following primers:. . Subsequently, a dissociation curve was run to verify amplification specificity. We used the 2 -CT method to calculate the relative expression levels (Livak and Schmittgen, 2001) . All the experiments were performed three times in triplicate and the mean ± s.d. was reported. Primers specific for the glucose-6-phosphate dehydrogenase (G6PD) were used for normalization of real time-quantitative PCR data. The following primer sequences were used to amplify the indicated genes:
Luciferase assay Cells were transfected with 1 mg of pLuc-ATM and with pCEFL-HA-HMGA1 or pCEFL-HA-HMGA2 expression vectors, together with 0.5-mg of pCMV-Renilla. Luciferase and Renilla activity were assessed with the Dual-Light Luciferase system (Promega, Fitchburg, WI, USA), 48 h after the transfection. The Luciferase activity was normalized for the Renilla activity. All the experiments were performed three times in triplicate and the mean ± s.d. was reported. 
Chromatin-immunoprecipitation assay
Comet assay
MEFs and FRO cells irradiated or not with 4 and 5 Gy of IR, respectively, were allowed to repair the DNA for 0 and 3 h in complete medium and then processed for the COMET assay (Trevigen, Helgerman, CT, USA) following manufacturer's instructions. Cell images were analyzed using COMET Score (TriTek, Annandale, VA, USA). Comet tail moment was used as the measure of DNA damage. In each experiment, 100 comets were measured per experimental point and the mean ± s.d. was reported.
Senescence assay
Early-passage MEFs were treated as described in results, and SA-b-gal activity was assessed by using Senescent Cells Staining kit (Sigma) following the manufacturer's instructions. Cells were analyzed with light microscopy to determine the percentage of senescent cells. At least 20 fields for each experimental point were analyzed. Reported values are the mean ± s.d. of three independent experiments.
Clonogenic assay
Cells were seeded at a density of 10 3 cells per 35-mm dish. After 1 day, cells were treated with different doses of IR. After 10 days, cells were stained with 500 mg/ml of crystal violet in 20% methanol, and resulting colonies were counted. The colony counts obtained were normalized for the untreated controls. The mean ± s.d. of three independent experiments performed in triplicate was reported.
Cell-cycle analysis Twenty-four hours following the seeding, cells were exposed to 5 Gy of IR. Where indicated, cells were also treated with 0.2 mg/ml of nocodazole, following the IR treatment. Cells were harvested at different time-points, fixed with ice-cold 70% ethanol, treated with RNase-I (Invitrogen) and stained with 10 mg/ml of propidium iodide. Cells were sorted on a FACS-Calibur flow cytometer (Becton Dickinson, San Diego, CA, USA), and the results were analyzed with ModFit software, 3.2 version (Verity Software House). Experiments were performed in triplicate and representative cell-cycle profiles were reported.
BrdU incorporation analysis
Twenty-four hours following the seeding, cells were treated with 2 mM thymidine for 16 h, then washed twice with PBS and cultured for 8 h in complete medium. Cells were then treated again with 2 mM thymidine for 17 h, to synchronize them in G1 phase of the cell cycle. Following the thymidine double block, cells were treated with 5 Gy of IR, and then cultured in complete medium containing 1 mM BrdU and harvested at different time-points. Harvested cells were fixed and stained using the BrdU Flow Kit (BD Pharmingen, San Diego, CA, USA), according to the manufacturer's instructions. Stained cells were analyzed by flow cytometry, as described above. The assay was performed three times in triplicate and the mean±s.d. was reported.
Apoptosis assays
Twenty-four hours after the seeding, FRO and FROasHMGA1 were untreated or exposed to 5 Gy of IR. Cells were then harvested after 24 h and stained with 10 mg/ml of propidium iodide and FITC-annexin-V antibody (BD Biosciences, San Diego, CA, USA), following manufacturer's instructions. Annexin-V-propidium iodide positive cells were analyzed using FACS-Calibur flow cytometer (Becton Dickinson). Experiments were performed in triplicate and representative annexin-V profiles were reported. Apoptosis was also quantified by measuring caspase 3 and 7 activation following the exposure to 2.5 or 5 Gy of IR, using Caspase-Glo 3/7 assay (Promega) according to the manufacturer's instructions on a Bio-Tek Synergy HT multi-detection microplate reader. The assay was performed three times in triplicate and the mean±s.d. was reported.
Statistical analysis
Student's t-test was used to determine significance. All error bars represent the s.d. of the mean. Statistical significance for all the tests, assessed by calculating the P-value, was o0.01.
